JNJ (STOCKS)
Johnson & Johnson
$240.000000
+1.670000 (+0.70%)
Prev close: $238.330000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joaquin Duato
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $579,778.94M
- Employees
- 139,800
- P/E (TTM)
- 27.85
- P/B (TTM)
- 7.14
- Dividend Yield
- 217.54%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $96.36B |
| Benefits Costs and Expenses | $71.42B |
| Cost Of Revenue | $31.01B |
| Costs And Expenses | $71.42B |
| Gross Profit | $65.36B |
| Operating Expenses | $40.42B |
| Selling, General, and Administrative Expenses | $24.60B |
| Other Operating Expenses | $15.71B |
| Operating Income/Loss | $24.94B |
| Income/Loss From Continuing Operations After Tax | $21.04B |
| Income/Loss From Continuing Operations Before Tax | $24.94B |
| Income Tax Expense/Benefit | $3.90B |
| Income Tax Expense/Benefit, Deferred | -$475.00M |
| Net Income/Loss | $21.04B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $21.04B |
| Net Income/Loss Available To Common Stockholders, Basic | $21.04B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $8.73 |
| Diluted Earnings Per Share | $8.64 |
| Basic Average Shares | 7,223,400,000 |
| Diluted Average Shares | 7,297,500,000 |
| Common Stock Dividends | $5.20 |
| Assets | $200.89B |
| Current Assets | $59.17B |
| Cash | $22.05B |
| Inventory | $14.58B |
| Other Current Assets | $22.54B |
| Noncurrent Assets | $141.72B |
| Fixed Assets | $23.27B |
| Intangible Assets | $49.06B |
| Other Non-current Assets | $69.39B |
| Liabilities | $119.71B |
| Current Liabilities | $57.72B |
| Accounts Payable | $10.46B |
| Wages | $2.91B |
| Other Current Liabilities | $44.35B |
| Noncurrent Liabilities | $61.99B |
| Equity | $81.19B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $81.19B |
| Liabilities And Equity | $200.89B |
| Net Cash Flow From Operating Activities | $22.87B |
| Net Cash Flow From Operating Activities, Continuing | $22.87B |
| Net Cash Flow From Investing Activities | -$24.33B |
| Net Cash Flow From Investing Activities, Continuing | -$24.33B |
| Net Cash Flow From Financing Activities | -$15.43B |
| Net Cash Flow From Financing Activities, Continuing | -$15.43B |
| Exchange Gains/Losses | $106.00M |
| Net Cash Flow | -$16.79B |
| Net Cash Flow, Continuing | -$16.89B |
| Comprehensive Income/Loss | $17.95B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $17.95B |
| Other Comprehensive Income/Loss | -$3.09B |